Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions

Universal use of face masks for success against COVID-19: evidence and implications for prevention policies

Susanna Esposito, Nicola Principi, Chi Chi Leung, Giovanni Battista Migliori
European Respiratory Journal 2020 55: 2001260; DOI: 10.1183/13993003.01260-2020
Susanna Esposito
1Pediatric Clinic, Pietro Barilla Children's Hospital, University of Parma, Parma, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: susanna.esposito@unimi.it
Nicola Principi
2Università degli Studi di Milano, Milan, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chi Chi Leung
3Hong Kong Tuberculosis, Chest and Heart Diseases Association, Hong Kong, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Giovanni Battista Migliori
4Servizio di Epidemiologia Clinica delle Malattie Respiratorie, Istituti Clinici Scientifici Maugeri IRCCS, Tradate, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Giovanni Battista Migliori
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Cloth masks are a simple, economic and sustainable alternative to surgical masks as a means of source control of SARS-CoV-2 in the general community https://bit.ly/2x2xTL4

To the Editor:

A debate is taking place on the use of face masks (both cloth and surgical) as a prevention tool in the community vis à vis the recent World Health Organization (WHO) recommendations. To shed light on this important topic, we reviewed relevant literature, focusing on the keywords “infection control”, “prevention”, “masks”, “respirators”, “viral infections” and “COVID-19”, without time restrictions to identify a minimum set of references from an electronic database (PUBMED), existing guidelines, viral diseases, airborne diseases and grey literature.

The core findings of the references identified are summarised in table 1.

View this table:
  • View inline
  • View popup
TABLE 1

Main studies on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission

According to the WHO report published in February 2020, the proportion of truly asymptomatic carriers of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was relatively small and was not a major driver of virus circulation, infection transmission and new disease development [15]. However, in blanket testing of an isolated village of ∼3000 people in northern Italy, 50–75% of people with positive pharyngeal molecular tests were totally asymptomatic [1]. This finding was echoed by a more recent daily surveillance report from China, where all people arriving from overseas were rigorously tested: among 166 persons with newly identified infections, 78% were asymptomatic [2]. Although the infective dose associated with transmission is not known, the viral load in the respiratory tract in an asymptomatic patient has been reported to be similar to patients with symptoms [3], and transmission of SARS-CoV-2 infection from an asymptomatic contact has also been described [4].

Until recently, it was thought that the virus could only be transmitted by droplets that are coughed or sneezed out or by contaminated fomites, with differences according to the initial load and surface characteristics [5]. Airborne transmission of SARS-CoV-2 was considered possible only when care procedures generating aerosols (e.g. intubation, bronchoscopy and positive-pressure ventilation) were performed [6]. However, other studies seemed to indicate the opposite, i.e. that the virus is present in exhaled air produced by talking and breathing [6]. Moreover, a potential role for aerosols in virus diffusion was evident in a complex laboratory study. Aerosols containing a viral load quite similar to that observed in human respiratory samples were created to generate an aerosolised environment. SARS-CoV-2 was detected ≤3 h after the start of the study [7]. Although these findings were not considered fully convincing by some authors [5], they deserve attention and further studies are required to establish whether and when airborne transmission of SARS-CoV-2 truly occurs and how it can be reduced.

It is well known that surgical masks can prevent the inhalation of large droplets and sprays but have limited ability to filter submicron-sized airborne particles [8, 9]. As SARS-CoV-2 is also embedded in aerosols <5 μm in diameter, it cannot be determined whether they are always effective. However, mask wearing by patients with pulmonary tuberculosis (an airborne infectious disease) has been shown to reduce infectivity to guinea pigs by 56% [9, 10]. The surgical mask has also been shown to intercept other human coronaviruses during coughing [11]. A meta-analysis of randomised controlled trials has also shown that surgical masks and N95 respirators were similarly effective in preventing influenza-like illness and laboratory-confirmed influenza among healthcare workers [12]. Similar results were obtained in a case–control study comparing the protective effect of surgical masks and N95 respirators against SARS among healthcare workers in five Hong Kong hospitals [13].

Controlling a respiratory infection at source using a face mask is a well-established strategy. For example, symptomatic patients with cough or sneezing are generally advised to put on a face mask, and this applies equally to patients with pulmonary tuberculosis (airborne transmission) and influenza (predominantly droplet-transmitted). With the large number of asymptomatic patients unaware of their own infection [1, 2], the comparable viral load in their upper respiratory tract [3], droplet and aerosol dispersion even during talking and breathing [6], and prolonged viral viability outside our body [7], we strongly advocate universal use of face masks as a means of source control in public places during the COVID-19 pandemic. Extreme forms of social distancing are not sustainable, and complete lockdown of cities or even whole countries is devastating to the economy. Universal masking in public complements social distancing and hand hygiene in containing or slowing down the otherwise exponential growth of the pandemic. Universal masking protects against cross-transmission through unavoidable person-to-person contact during the lockdown and reduces the risk for resurgence during relaxation of social distancing measures.

A high degree of compliance will maximise the impact of universal masking in public. The global shortage of surgical masks and N95 respirators is a serious concern. In line with the recent recommendation by the US Centers for Disease Control and Prevention (CDC) for healthy people to wear a cloth face cover in public [14], we strongly support the use of cloth masks as a simple, economic and sustainable alternative to surgical masks as a means of source control for general community use, so that disposable surgical masks and N95 respirators can be reserved for use in healthcare facilities. Such an intervention is likely to be life saving in many resource-limited settings.

Shareable PDF

Supplementary Material

This one-page PDF can be shared freely online.

Shareable PDF ERJ-01260-2020.Shareable

Acknowledgements

The article is part of the activities of WAidid (World Association for Infectious Diseases and Immunological Disorders), the Global Tuberculosis Network (GTN) and the WHO Collaborating Centre for Tuberculosis and Lung Diseases, Tradate (ITA-80, 2017-2020-GBM/RC/LDA).

Footnotes

  • Author contributions: S. Esposito and N. Principi co-wrote the manuscript. G.B. Migliori and C.C. Leung wrote sections of the manuscript, edited the text for major intellectual components and designed the table. All authors approved the text.

  • Conflict of interest: S. Esposito has nothing to disclose.

  • Conflict of interest: N. Principi has nothing to disclose.

  • Conflict of interest: C.C. Leung has nothing to disclose.

  • Conflict of interest: G.B. Migliori has nothing to disclose.

  • Received April 18, 2020.
  • Accepted April 21, 2020.
  • Copyright ©ERS 2020
http://creativecommons.org/licenses/by-nc/4.0/

This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.

References

  1. ↵
    1. Day M
    . Covid-19: identifying and isolating asymptomatic people helped eliminate virus in Italian village. BMJ 2020; 368: m1165. doi:10.1136/bmj.m1165
    OpenUrlFREE Full Text
  2. ↵
    1. Day M
    . Covid-19: four fifths of cases are asymptomatic, China figures indicate. BMJ 2020; 369: m1375. doi:10.1136/bmj.m1375
    OpenUrlFREE Full Text
  3. ↵
    1. Zou L,
    2. Ruan F,
    3. Huang M, et al.
    SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N Engl J Med 2020; 382: 1177–1179. doi:10.1056/NEJMc2001737
    OpenUrlCrossRefPubMed
  4. ↵
    1. Rothe C,
    2. Schunk M,
    3. Sothmann P, et al.
    Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. N Engl J Med 2020; 382: 970–971.
  5. ↵
    World Health Organization. Modes of transmission of virus causing COVID-19: implications for IPC precaution recommendations. https://www.who.int/news-room/commentaries/detail/modes-of-transmission-of-virus-causing-covid-19-implications-for-ipc-precaution-recommendations Date last accessed: 3 April 2020.
  6. ↵
    1. Lewis D
    . Is the coronavirus airborne? Experts can't agree. Nature 2020; 580: 175. doi:10.1038/d41586-020-00974-w
    OpenUrl
  7. ↵
    1. van Doremalen N,
    2. Bushmaker T,
    3. Morris DH, et al.
    Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N Engl J Med 2020; 382: 1564–1567. doi:10.1056/NEJMc2004973
    OpenUrlCrossRefPubMed
  8. ↵
    University of Maryland. Wearing surgical masks in public could help slow COVID-19 pandemic's advance: masks may limit the spread diseases including influenza, rhinoviruses and coronaviruses.” https://www.sciencedaily.com/releases/2020/04/200403132345.htm Date last updated: 3 April 2020. Date last accessed: 3 April 2020.
  9. ↵
    1. Migliori GB,
    2. Nardell E,
    3. Yedilbayev A, et al.
    Reducing tuberculosis transmission: a consensus document from the World Health Organization Regional Office for Europe. Eur Respir J 2019; 53: 1900391. doi:10.1183/13993003.00391-2019
    OpenUrlAbstract/FREE Full Text
  10. ↵
    1. Dharmadhikari AS,
    2. Mphahlele M,
    3. Stoltz A, et al.
    Surgical face masks worn by patients with multidrug-resistant tuberculosis: impact on infectivity of air on a hospital ward. Am J Respir Crit Care Med 2012; 185: 1104–1109. doi:10.1164/rccm.201107-1190OC
    OpenUrlCrossRefPubMedWeb of Science
  11. ↵
    1. Leung NHL,
    2. Chu DKW,
    3. Shiu EYC, et al.
    Respiratory virus shedding in exhaled breath and efficacy of face masks. Nat Med 2020; 26: 1–5. doi:10.1038/s41591-020-0843-2
    OpenUrl
  12. ↵
    1. Long Y,
    2. Hu T,
    3. Liu L, et al.
    Effectiveness of N95 respirators versus surgical masks against influenza: a systematic review and meta-analysis. J Evid Based Med 2020; in press [https://doi.org/10.1111/jebm.12381].
  13. ↵
    1. Seto WH,
    2. Tsang D,
    3. Yung RW, et al.
    Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory syndrome (SARS). Lancet 2003; 361: 1519–1520. doi:10.1016/S0140-6736(03)13168-6
    OpenUrlCrossRefPubMedWeb of Science
  14. ↵
    Centers for Disease Control and Prevention. Coronavirus Disease 2019 (COVID-19). How to Protect Yourself & Others. https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/prevention.html Date last accessed: 3 April 2020.
  15. ↵
    World Health Organization. Report of the WHO-China joint mission on coronavirus disease 2019 (COVID-19). https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf Date last accessed: 1 April 2020.
PreviousNext
Back to top
View this article with LENS
Vol 55 Issue 6 Table of Contents
European Respiratory Journal: 55 (6)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Universal use of face masks for success against COVID-19: evidence and implications for prevention policies
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Universal use of face masks for success against COVID-19: evidence and implications for prevention policies
Susanna Esposito, Nicola Principi, Chi Chi Leung, Giovanni Battista Migliori
European Respiratory Journal Jun 2020, 55 (6) 2001260; DOI: 10.1183/13993003.01260-2020

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Universal use of face masks for success against COVID-19: evidence and implications for prevention policies
Susanna Esposito, Nicola Principi, Chi Chi Leung, Giovanni Battista Migliori
European Respiratory Journal Jun 2020, 55 (6) 2001260; DOI: 10.1183/13993003.01260-2020
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Shareable PDF
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

Agora

  • Airway immune responses to COVID-19 vaccination in COPD patients
  • Wider access to rifapentine-based regimens is needed for TB care globally
  • Association between immunosuppressants and outcomes of COVID-19
Show more Agora

Correspondence

  • Clinical outcomes of bronchiectasis in India
  • Reply: Clinical outcomes of bronchiectasis in India
  • Reply: Risk factors for disease progression in fibrotic hypersensitivity pneumonitis
Show more Correspondence

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society